Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 4Glioma 2Central Nervous System Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Meningioma 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoma 1Brain Neoplasms 1

Interventions

Trastuzumab 2Radiotherapy 2Capecitabine 2tucatinib 1sapanisertib 1pertuzumab 1patritumab deruxtecan 1paclitaxel-Angiopep-2 conjugate 1omburtamab I-131 1fludarabine 1eribulin 1avelumab 1WP 744 1Temozolomide 1Spinal Puncture 1Rituximab 1Psychiatric Rehabilitation 1Phlebotomy 1Methotrexate 1Cyclophosphamide 1Amplified Fragment Length Polymorphism Analysis 1AZD1390 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Neoplasms × avelumab × CNS × Clear all
NCT03719768 2026-03-02

Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
16 enrolled
CNS

Brain Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡